These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21127352)

  • 21. [Cellular and molecular pharmacology. A new approach to the mode of action and the toxicity of medications].
    Deysson G; Migne J
    Biol Med (1971); 1974 Jun; 3(1):21-63. PubMed ID: 4470700
    [No Abstract]   [Full Text] [Related]  

  • 22. Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: a preliminary study using a multiplexing approach.
    Gerets HH; Hanon E; Cornet M; Dhalluin S; Depelchin O; Canning M; Atienzar FA
    Toxicol In Vitro; 2009 Mar; 23(2):319-32. PubMed ID: 19110050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabonomics in pharmaceutical R&D.
    Lindon JC; Holmes E; Nicholson JK
    FEBS J; 2007 Mar; 274(5):1140-51. PubMed ID: 17298438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative analysis of acute-phase proteins as inflammatory biomarkers in preclinical toxicology studies: implications for preclinical to clinical translation.
    Watterson C; Lanevschi A; Horner J; Louden C
    Toxicol Pathol; 2009 Jan; 37(1):28-33. PubMed ID: 19171926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies to improve in vivo toxicology outcomes for basic candidate drug molecules.
    Luker T; Alcaraz L; Chohan KK; Blomberg N; Brown DS; Butlin RJ; Elebring T; Griffin AM; Guile S; St-Gallay S; Swahn BM; Swallow S; Waring MJ; Wenlock MC; Leeson PD
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5673-9. PubMed ID: 21852131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.
    Whitebread S; Hamon J; Bojanic D; Urban L
    Drug Discov Today; 2005 Nov; 10(21):1421-33. PubMed ID: 16243262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical testing on insects predicts human haematotoxic potentials.
    Berger J
    Lab Anim; 2009 Oct; 43(4):328-32. PubMed ID: 19505933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomics-based parallel discovery of xenobiotics and induced endogenous metabolic dysregulation in clinical toxicology.
    Chen C; Fan Z; Xu H; Tan X; Zhu M
    Biomed Chromatogr; 2019 Feb; 33(2):e4413. PubMed ID: 30357883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use and application of stem cells in toxicology.
    Davila JC; Cezar GG; Thiede M; Strom S; Miki T; Trosko J
    Toxicol Sci; 2004 Jun; 79(2):214-23. PubMed ID: 15014205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sensitivity of metabolomics versus classical regulatory toxicology from a NOAEL perspective.
    van Ravenzwaay B; Montoya GA; Fabian E; Herold M; Krennrich G; Looser R; Mellert W; Peter E; Strauss V; Walk T; Kamp H
    Toxicol Lett; 2014 May; 227(1):20-8. PubMed ID: 24657160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicoproteomics: new paradigms in toxicology research.
    George J; Singh R; Mahmood Z; Shukla Y
    Toxicol Mech Methods; 2010 Sep; 20(7):415-23. PubMed ID: 20175663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism, disposition, and toxicity of drugs and other xenobiotics in aquatic species.
    Guarino AM; Lech JJ
    Vet Hum Toxicol; 1986; 28 Suppl 1():38-44. PubMed ID: 3334693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
    Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical and toxicological significance of toxicity mechanisms].
    Gillmann H
    Arzneimittelforschung; 1977; 27(96):1819-20. PubMed ID: 579146
    [No Abstract]   [Full Text] [Related]  

  • 35. [Toxicology animal studies necessary for clinical research and registration of drugs for human use: conclusions of the International Harmonization Conference (I)].
    Rubio Terrés C; Duque I; Tristán C; Galende I
    Med Clin (Barc); 1993 Nov; 101(18):705-16. PubMed ID: 8114529
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways.
    Xu EY; Schaefer WH; Xu Q
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):40-52. PubMed ID: 19152212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety evaluation to support First-In-Man investigations II: toxicology studies.
    Baldrick P
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):237-43. PubMed ID: 18501490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of diet on the metabolism and toxicology of drugs.
    Ioannides C; Parke DV
    J Hum Nutr; 1979 Oct; 33(5):357-66. PubMed ID: 115915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
    Buckley LA; Dorato MA
    Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Juvenile animal toxicity study designs to support pediatric drug development.
    Cappon GD; Bailey GP; Buschmann J; Feuston MH; Fisher JE; Hew KW; Hoberman AM; Ooshima Y; Stump DG; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):463-9. PubMed ID: 20025047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.